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Hand involvementAbstract Aim of the work: The aim of the present study is to assess bone mineral density (BMD)
in systemic sclerosis (SSc) patients and to determine associated factors.
Patients and methods: Sixty-ﬁve female SSc patients (mean age 39.5 ± 13.5 years, disease dura-
tion 7.3 ± 5.9 years), and forty age- and sex- matched controls were included. Forty-seven patients
had limited SSc and 18 had diffuse type. Patients were subjected to clinical and functional assess-
ment. BMD was quantiﬁed at the distal radius, femoral neck and lumbar spine (L2–4) by dual
energy X-ray absorptiometry.
Results: SSc patients had a higher frequency of osteoporosis at the distal radius and osteopenia
at the lumbar spine (p= 0.001 and 0.002, respectively), but the BMD at the femoral neck was not
signiﬁcantly different from the control group. Patients with osteoporosis at the distal radius had a
signiﬁcantly higher frequency of hand deformities (p< 0.05) and higher functional scores reﬂecting
more disability than patients without (p= 0.01), while patients with osteoporosis at the lumbar
spine were signiﬁcantly older (p< 0.001) and had a longer disease duration than those without
(p= 0.001). No associations were found between menopausal status, SSc subtype, skin score, inter-
nal organ affection and osteoporosis at the three skeletal sites.
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and lumbar spine. Osteoporosis at the distal radius is associated with the presence of hand defor-
mity and functional disability, while osteoporosis at the lumbar spine is associated with older age
and longer disease duration.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society for Joint Diseases and
Arthritis. Open access under CC BY-NC-ND license.1. Introduction
Systemic sclerosis (SSc) is a disease of unknown cause, the hall-
mark of which is induration of the skin. It is characterized by a
universal functional and structural vasculopathy, inﬂammation,
immunological abnormalities in most cases and ultimately
ﬁbrosis due to deposition of extracellular matrix components
resulting in tissue destruction and organ dysfunction [1,2].
Osteoporosis and related fragility fractures are among the most
common complications that occur in patients who have rheu-
matic diseases, and they contribute to a dramatic decrease in
quality of life [3]. SSc patients suffer from a chronic inﬂamma-
tory state, are exposed to secondary risk factors for osteoporosis
including inactivity, low body mass index, decreased vitamin D
synthesis in the ﬁbrotic skin, involvement of the intestinal tract
and kidneys that may impair calcium metabolism, earlier men-
opause in addition to medications used to treat complications
of SSc (corticosteroids and cyclophosphamide) [3,4]. Although
several authors found lower bone mineral density (BMD) in
systemic sclerosis patients in comparison to age and sexmatched
controls [5–10], this was not conﬁrmed in other studies [11,12];
therefore, whether SSc is associated with an increased risk of
osteoporosis remains inconclusive.
The aim of the present study was to assess the BMD status
in patients with SSc and its association with disease manifesta-
tions and possible confounding factors.
2. Patients and methods
Sixty-ﬁve female patients with SSc were consecutively recruited
from the Rheumatology and Rehabilitation department, Fac-
ulty of Medicine, Cairo University. The study was approved
by the local ethics committee and conforms with the declara-
tion of Helsinki. All patients satisﬁed the preliminary Ameri-
can Rheumatology Association criteria for classiﬁcation of
progressive SSc [13]. They had a mean age 39.5 ± 13.5 years,
range 17–68 years. Twenty-nine patients were postmenopausal
(44.6%); 8 developed menopause before the onset of SSc
(preSSc) and 21 after the onset of SSc (post SSc). The control
group consisted of 40 age matched healthy females; 22 were
postmenopausal (44%). The frequency of menopause was
not statistically signiﬁcantly different between patients and
controls (p> 0.05).
Patients were classiﬁed according to the extent of cutaneous
involvement as diffuse and limited SSc using the criteria of
LeRoy, et al., [14].
The exclusion criteria were male sex, history of smoking
and treatment with hormone replacement therapy and other
drugs for osteoporosis.
The following personal and disease parameters were in-
cluded: age, disease duration, age at disease onset, menopausal
status and its relation to disease onset, presence of arthritis and
deformities as well as features of hand radiographs. Theinvolvement of internal organs was determined and current
or previous treatment was recorded. Functional assessment
was done according to Silman, et al., [15]. This scoring system
was developed to assess disability in activities of daily living in
SSc patients and contains 11 items; each is given a score from 0
to 3 (0 = able to perform in normal manner, 1 = can manage
with some alteration in style, 2 = can only manage with difﬁ-
culty, 3 = impossible to achieve). The total possible score is
33, with higher scores indicating more disability.
Modiﬁed Rodnan Skin Score (mRSS) was used for assess-
ment of skin thickness by palpation at 17 surface anatomical
sites, graded from 0 (normal) to 3 (severe thickening) with a
maximum of 51 points [16].
The delta ﬁnger-to-palm distance (FTP) was used to assess
the ﬁnger range of motion as described by Torok, et al., [17]. A
ruler is used to measure the distance (in centimeters) between
the 3rd ﬁngertip and the distal palmar crease while the patient
attempts full ﬁnger extension minus the standard FTP, which
is obtained by measuring the distance between the tip of the
pulp of the 3rd ﬁnger and the distal palmar crease while the pa-
tient attempts to make a full ﬁst (maximal ﬁnger ﬂexion at the
metacarpo–phalangeal, proximal interphalangeal and distal
interphalangeal joints).
The following serologic tests were included: rheumatoid
factor, antinuclear antibodies, anticentromere antibodies and
anti-Scl 70.
Bone mineral density (BMD) was quantiﬁed by dual energy
X ray absorptiometry, (Prodigy GE Lunar) at the lumbar
spine L2–L4, femoral neck, and distal radius. BMD was mea-
sured in g/cm2 and T-score (deviation with respect to peak
bone mass) and was assessed by the same radiologist.
Patients were divided into three groups according to the
BMD ﬁndings: patients with normal BMD; T score > 1, pa-
tients with osteopenia; T score between 1 and 2.5 and pa-
tients with osteoporosis; T score 6 2.5.
Statistical methods: Data were processed on a personal
computer using the statistical package SPSS (version 11) for
windows. For descriptive statistics, data were expressed as fre-
quency, range, median, mean ± standard deviation (SD). For
comparisons between means, two-tailed t-tests were used. For
comparison between categorical variables, the Chi square test
was used. Correlations were done using Pearson’s correlation
coefﬁcient. Statistical signiﬁcance was set at p< 0.05.
3. Results
Sixty-ﬁve female patients with SSc were involved in this study.
The mean age was 39.5 ± 13.5 (range 17–68 years), the mean
age at disease onset was 32.6 ± 11.5 (range 16–58 years),
and the mean disease duration was 7.3 ± 5.9 (range 0.5–
25 years). Forty-seven patients had limited SSc (lSSc), and 18
patients had diffuse type (dSSc). All patients received calcium
channel blockers at some time during the course of their
Table 1 Comparison of bone mineral density between SSc patients and controls at the distal radius, femoral neck and lumbar spine.
Age Osteopenia at
distal radius (n)
Osteoporosis at
distal radius (n)
Osteopenia at
femoral neck (n)
Osteoporosis at
femoral neck (n)
Osteopenia at
lumbar spine (n)
Osteoporosis at
lumbar spine (n)
Patients (n= 65) 39.5 ± 13.5 22 34 19 12 26 14
Controls (n= 40) 38.3 ± 13.8 9 3 11 5 5 5
P value NS X2 = 0.084 X2 = 0.001 X2 = 0.173 X2 = 0.162 X2 = 0.002 X2 = 0.109
Table 2 Comparison between patients with osteoporosis at the distal radius, femoral neck and lumbar spine and those without.
SSc patients
(n= 65)
Patients with
osteoporosis
at the distal
radius(n= 34)
Sig. Patients with
osteoporosis
at the femoral
neck (n= 12)
Sig. Patients with
lumbar osteoporosis
n= 15
Sig.
Patients without
forearm osteoporosis
(n= 31)
Patients without
osteoporosis at the
femoral neck (n= 53)
Patients without
lumbar osteoporosis
(n= 50)
Age (y)** 39.5 ± 13.5 41.8 ± 12.2 NS 46 ± 7.04 NS 50.14 ± 7.17 P< 0.001
36.87 ± 14.67 39.4 ± 13.7 36.5 ± 13.5
Disease duration
(y)**
7.33 ± 5.86 8.01 ± 6.3 NS 11.75± 8.55 NS 9.75± 6.80 P= 0.001
5.9 ± 4.66 6.4 ± 5.1 6.3 ± 5.2
Age at disease onset
(y)**
32.6 ± 11.53 34.1 ± 11.1 NS 35.9 ± 10.72 NS 41.03 ± 9.42 NS
30.96 ± 11.93 31.8 ± 11.3 30.3 ± 11
Menopause before
onset of SSc: n (%)
8 (12.3) 4 NS 1 NS 4 NS
4 7 4
Menopause now:
n (%)
21 (32.3) 13 NS 1 NS 10 NS
8 20 11
DSSc n (%) 18 (27.7) 8 NS 5 NS 2 NS
10 13 16
LSSc n (%) 47 (72.3) 26 NS 2 NS 13 NS
21 45 34
Functional score*** 14 (0–33) 18 (0–33) P= 0.01 18.5 (9–23) NS 15 (2–23) NS
10 (0–33) 12 (0–33) 12 (0–33)
Esophageal
dysmotility n (%)
44 (67.7) 24 NS 10 NS 12 NS
20 34 32
Interstitial lung
disease n (%)
10 (15.4) 7 NS 0 _ 5 NS
3 10 5
Heart disease n (%) 15 (23.1) 8 NS 5 NS 6 NS
7 10 9
Raynaud’s
phenomenon n (%)
63 (96.9) 33 NS 5 NS 13 NS
30 58 50
Skin score *** 13 (6–40) 13 (7–40) NS 12.5 (7–40) NS 14 (6–40) NS
15 (6–28) 13 (6–40) 13 (6–36)
** = mean ± SD, *** = median (range).
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of 5–40 mg/day for 1–72 months. High doses of corticosteroids
were needed for patients with interstitial pneumonitis and were
gradually tapered during the disease course. Cyclophospha-
mide IV pulses were given to 4 patients at a dose of 750–
1000 mg/m2 surface area monthly for 6 months then every
3 months over 2 years. Sixteen patients received methotrexate
IM 12.5–17.5 mg/week for a duration of 6–24 months.
The bone mineral density (BMD) ﬁndings of patients and
controls are described in Table 1. The BMD at the distal radius
in SSc patients was signiﬁcantly less than that in controls
(0.46 ± 0.40 vs. 0.84 ± 0.18, p< 0.001). SSc patients had also
a signiﬁcantly higher frequency of osteoporosis at the distal
radius (p= 0.001) in comparison to the control group. SSc
patients had a higher frequency of osteopenia at the lumbar
spine (p= 0.002), while the frequency of osteopenia andosteoporosis at the femoral neck was not signiﬁcantly different
from the control group.
The general characteristics of all SSc patients, patients with
and without detected osteoporosis at the distal radius, femoral
neck and lumbar spine are described in Table 2. Patients with
osteoporosis at the distal radius had signiﬁcantly higher func-
tional scores compared to those without (p= 0.01), while
there was no statistically signiﬁcant difference in the functional
score between patients with and without osteoporosis at the
femoral neck and lumbar spine. Patients with osteoporosis at
the lumbar spine were signiﬁcantly older (p< 0.001) and
had a longer disease duration (p= 0.001) than those without,
while age and disease duration were not signiﬁcantly different
between patients with and without osteoporosis at the distal
forearm and the femoral neck. Age at disease onset, develop-
ment of menopause before the onset of SSc, menopausal
Table 3 Comparison between patients with and without osteoporosis at the distal radius concerning hand condition.
Patients with osteoporosis
at the distal radius (n= 34)
Patients without osteoporosis
at the distal radius (n= 31)
P
BMD at distal radius(g/cm2)** 0.318 ± 0.08 0.609 ± 0.54 P< 0.01
Hand deformity 27 16 P< 0.05
Hand arthritis 6 5 NS
RF+ ve 3 1 NS
Skin score** 15.62 ± 8.95 15.19 ± 7.93 NS
Delta FTP (cm) ** *** 3.49 ± 2.433 (0.5–11) 4.45 ± 2.39 4 (0–10) NS
** = mean ± SD, *** = median (range).
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disease, heart affection, Raynaud’s phenomenon and skin
score did not differ signiﬁcantly between patients with and
without osteoporosis at the three skeletal sites. Furthermore,
there was no association between the intake of calcium channel
blockers, corticosteroids, cyclophosphamide or methotrexate
and osteoporosis at any site (data are not shown).
Since a higher frequency of osteoporosis was found at the
distal radius in SSc patients in comparison to the control
group, we sought to determine associated factors. The limita-
tion of hand range of motion was measured by delta FTP.
Although BMD at the distal radius in all patients
(3.9 ± 2.4 cm) was signiﬁcantly correlated with delta FTP val-
ues (r= 0.36, p< 0.01), the comparison of delta FTP between
patients with osteoporosis at the distal radius and those with-
out revealed no statistically signiﬁcant difference.
Forty-three patients with SSc had hand deformities in the
form of ﬂexion contractures. Deformities were related to skin
tightness in 36 patients (83.7%), and related to hand arthritis
in 7 patients (16.3%). Hand radiographs revealed erosions in
5 patients (7.7%), resorption of ﬁnger tips in 33 patients
(50.7%) and calcinosis in 11 patients (16.9%). None of the pa-
tients had digital fractures. Patients with hand deformities had
a signiﬁcantly lower delta FTP than those without; mean
3.3 ± 2, median 3, range 0.5–10 cm versus a mean of
5.2 ± 2.7, median 4.3, range 0–11 cm, p= 0.002. Signiﬁcantly
higher functional scores were found in patients with hand
deformities as compared to those without; mean score
15.9 ± 8.9, median 18, range 0–33 versus a mean score of
8.6 ± 8.5, median 6, range 0–32, p= 0.002. Hand deformity
was detected more frequently in patients with osteoporosis at
the distal radius compared to those without (p< 0.05), while
the frequencies of hand arthritis and RF positivity as well as
mean skin scores were not signiﬁcantly different between both
groups, (Table 3).
4. Discussion
Several authors found SSc patients to have lower bone mineral
density (BMD) in comparison to age and sex matched controls
[5–10,18,19]. Furthermore, the prevalence of osteoporosis in
SSc has been found to be comparable to that in positive con-
trols with rheumatoid arthritis [19,20]. In the present study,
a higher incidence of low bone mineral density was detected
in SSc patients at the distal radius (p= 0.001) and lumbar
spine (p= 0.002).
La Montagna, et al., [5] found that the percentage of SSc
patients in menopause was signiﬁcantly greater than that ofthe controls (p< 0.001) with menopause occurring in the
SSc patients signiﬁcantly earlier than in controls (p< 0.001).
It was suggested that earlier menopause can play a role in
the induction of osteopenia in systemic sclerosis. Also, lower
BMD was more marked with estrogen deﬁciency in the study
by Frediani, et al., [8]. IbnYacoub, et al., [18] also found SSc
patients to have an earlier age and longer duration of meno-
pause. On the other hand, another study found no statistically
signiﬁcant differences in age at menarche and menopause and
estrogen use between SSc patients and controls [7]. In the pres-
ent study, the frequency of menopause was not signiﬁcantly
different between SSc patients and age- matched controls
and menopausal status was not associated with the presence
of osteoporosis, which was also found in a recent study [19].
The development of menopause before the onset of systemic
sclerosis was also not associated with osteoporosis at the distal
radius, lumbar spine or femoral neck.
In the present study, a higher frequency of osteoporosis was
found at the distal radius (p= 0.001) in SSc patients as com-
pared to controls, conﬁrming the previous work [5,6,21]. Flex-
ion contractures contributing to decreased hand function,
functional disability and work disability in SSc are frequently
found [22,23]. In the present study, 43/65 SSc patients with
hand deformities had signiﬁcantly more impaired hand mobil-
ity as compared to those without deformities (p= 0.002) and
higher functional scores, indicating more disability
(p= 0.002). Osteoporosis at the distal radius was signiﬁcantly
associated with hand deformity (p< 0.05), higher functional
scores (p= 0.01), and the BMD was positively correlated with
the delta FTP distance (r= 0.36, p< 0.01), reﬂecting the ef-
fect of hand immobilization and functional disability on the
bone mineral density at the distal radius. Interestingly, the fre-
quencies of hand arthritis and RF positivity were not statisti-
cally signiﬁcantly different between patients with and
without osteoporosis at the distal radius.
A higher frequency of low bone mineral density in the form
of osteopenia was found at the lumbar spine in SSc patients as
compared to controls (p= 0.002) which is in agreement with
several authors [6,8,10,19,24] but not with others [7,11]. In
the present study, patients with osteoporosis at the lumbar
spine were signiﬁcantly older and had a longer disease dura-
tion than those without (p< 0.001 and p= 0.001, respec-
tively), which is in agreement with Avouac, et al., [19].
Frediani, et al., [8], however, stated that the lower BMD in
SSc patients was more marked with age but not related to dis-
ease duration. In agreement with our results, signiﬁcant nega-
tive correlations were found between BMD and disease
duration by Di Munno, et al., [6] and Ibn Yakoub, et al., [18].
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oral neck was not signiﬁcantly different from the control
group. This is in agreement with da Silva, et al., [11]. Newman,
et al., [12] had also reported that most of their patients had
normal or increased BMD, however, several authors found
lower BMD at the proximal femur in SSc patients [7–
10,19,24]. SSc patients reported signiﬁcantly less physical
activity than controls which could have accounted for the low-
er BMD at the proximal femur in those patients [7]. Another
study also reported more disability in SSc patients compared
to control patients with non-inﬂammatory musculoskeletal
disease [20]. In the present study, although functional scores
reﬂecting disability were higher in SSc patients with osteoporo-
sis at the femoral neck compared to those without (median
18.5 and 12, respectively), the difference was not statistically
signiﬁcant.
In the present study, no association was found between pa-
tients with and without osteoporosis at the distal radius,
lumbar spine and femoral neck and scleroderma subtype.
This is in agreement with some authors [9,11,19]. Di Munno
et al., [6] and Frediani, et al., [8] found lower BMD in diffuse
SSc. Ibn Yacoub, et al., [18] found signiﬁcant negative
correlations between Rodnan score and BMD at the lumbar
spine and proximal femur, while in the present study, Rodnan
score was not associated with osteoporosis at the three skeletal
sites.
Internal organ affection was associated with lower BMD in
SSc patients in some studies [8,11,18]. We and others [6,19],
however, did not ﬁnd an association between BMD and inter-
nal organ affection. Ibn Yakoub, et al., [18] also found a sig-
niﬁcant association between BMD and severe joint
involvement, which was not conﬁrmed in the present study.
These discrepancies could be considered to result from patient
selection bias, because the most severe disease is more likely to
be inﬂuenced by other risk factors for osteoporosis, such as
inactivity, poor nutritional state, chronic renal failure, and
medications (corticosteroids and cyclophosphamide) [3].
SSc patients were found by some authors to have lower
vitamin D levels than controls that were related to the lower
bone mass in SSc patients [18,19]. One limitation of the present
study is the absence of vitamin D levels in our patients and the
control group, however, low vitamin D levels would have been
expected to cause generalized osteoporosis which is not the
case in this study.
In conclusion, patients with systemic sclerosis have lower
bone mineral density than controls at the distal radius and
lumbar spine. Osteoporosis at the distal radius is associated
with the presence of hand deformity and functional disability,
while osteoporosis at the lumbar spine is associated with older
age and longer disease duration. Physiotherapy to improve
hand mobility and function in SSc patients is recommended.
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